Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2026 · third_quarter · Q3
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings, licensure of blood centers
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Source: Senate LDA
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2026 · second_quarter · Q2
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings, licensure of blood centers
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2026 · first_quarter · Q1
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings, licensure of blood centers
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2025 · fourth_quarter · Q4
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings, licensure of blood centers
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2025 · third_quarter · Q3
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings, licensure of blood centers
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2025 · second_quarter · Q2
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2025 · first_quarter · Q1
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests, testing of blood donations for Malaria
Blood centers disaster preparedness and response activities, cybersecurity of the naton's blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2024 · fourth_quarter · Q4
Value of Blood/Reimbursement, laboratory developed tests, testing of blood donations for Malaria
Blood centers disaster preparedness and response activities, cybersecurity
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, infectious disease testing, access to blood in hospice and pre-hospital settings
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2024 · third_quarter · Q3
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests, testing of blood donations for Malaria
Blood centers disaster preparedness and response activities, cybersecurity
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2024 · second_quarter · Q2
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2024 · first_quarter · Q1
Value of Blood/Reimbursement, laboratory developed tests
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2023 · fourth_quarter · Q4
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2023 · third_quarter · Q3
Value of Blood/Reimbursement, laboratory developed tests
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2023 · second_quarter · Q2
Value of Blood/Reimbursement, laboratory developed tests
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2023 · first_quarter · Q1
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings
Value of Blood/Reimbursement, laboratory developed tests
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2022 · fourth_quarter · Q4
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma, laboratory developed tests
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2022 · third_quarter · Q3
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma, laboratory developed tests
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2022 · second_quarter · Q2
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing.
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma, laboratory developed tests
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2022 · first_quarter · Q1
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing.
Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2021 · fourth_quarter · Q4
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma, infectious disease testing.
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2021 · third_quarter · Q3
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma, infectious disease testing.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2021 · second_quarter · Q2
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma, infectious disease testing.
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2021 · first_quarter · Q1
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply, collection and distribution of convalescent plasma.
Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma, infectious disease testing.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2020 · fourth_quarter · Q4
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2020 · third_quarter · Q3
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma
Value of Blood/Reimbursement Bacterial risk strategies for platelets Deferral policies for blood donors
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2020 · second_quarter · Q2
Value of Blood/Reimbursement Bacterial risk strategies for platelets Testing of blood for Zika virus Deferral policies for blood donors
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, collection and distribution of convalescent plasma
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2020 · first_quarter · Q1
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy Date of Service policy applicability to blood centers Cost of FDA bacterial mitigation strategies guidance
Value of Blood/Reimbursement Bacterial risk strategies for platelets Testing of blood for Zika virus
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act, impact of COVID-19 on the blood supply
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2019 · fourth_quarter · Q4
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
Value of Blood/Reimbursement Blood center testing for Babesia Bacterial risk strategies for platelets Testing of blood for Zika virus
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy Date of Service policy applicability to blood centers Cost of FDA bacterial mitigation strategies guidance
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2019 · third_quarter · Q3
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy Date of Service policy applicability to blood centers
Value of Blood/Reimbursement Blood center testing for Babesia Bacterial risk strategies for platelets
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2019 · second_quarter · Q2
Value of Blood/Reimbursement Blood center testing for Babesia Bacterial risk strategies for platelets
Value/Sustainability of Blood; Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy Date of Service policy applicability to blood centers
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2019 · first_quarter · Q1
Value/Sustainability of Blood; Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Value of Blood/Reimbursement Blood center testing for Zika Blood center testing for Babesia Bacterial risk strategies for platelets
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2018 · fourth_quarter · Q4
Value/Sustainability of Blood; Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
Value of Blood/Reimbursement Blood center testing for Zika Blood center testing for Babesia Bacterial risk strategies for platelets
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2018 · third_quarter · Q3
Value of Blood/Reimbursement Blood center testing for Zika Blood center testing for Babesia Bacterial risk strategies for platelets
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
Value/Sustainability of Blood; Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2018 · second_quarter · Q2
Value/Sustainability of Blood; Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2018 · first_quarter · Q1
Value/Sustainability of Blood; Blood and blood product reimbursement
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement Blood center testing for Zika
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2017 · second_quarter · 2A
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Value/Sustainability of Blood; Blood and blood product reimbursement
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2017 · fourth_quarter · Q4
Value/Sustainability of Blood; Blood and blood product reimbursement
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement Blood center testing for Zika
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2017 · third_quarter · Q3
Value/Sustainability of Blood; Blood and blood product reimbursement
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2017 · second_quarter · Q2
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Value/Sustainability of Blood; Blood and blood product reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2017 · first_quarter · Q1
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Value/Sustainability of Blood; Blood and blood product reimbursement
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2016 · fourth_quarter · Q4
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Value of Blood/Reimbursement
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S BLOOD CENTERS via AMERICA'S BLOOD CENTERS
2016 · third_quarter · Q3
Value of Blood/Reimbursement
Universal product label for component plasma Quality control requirements for blood centers Universal Freezing Time for Source Plasma Value of Blood/Reimbursement
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Value of Blood/Reimbursement Bacterial risk strategies for platelets Deferral policies for blood donors
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Value of Blood/Reimbursement, reimbursement for COVID-19 convalescent plasma
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Value of Blood/Reimbursement
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Blood supply data platform; value of blood; blood and blood product reimbursement, recruitment of blood donors, blood donation awareness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Blood centers disaster preparedness and response activities related to the Pandemic and All-Hazards Preparedness Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Value of Blood/Reimbursement Blood product HCPCS P-code taxonomy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Value of Blood/Reimbursement Blood center testing for Zika Bacterial risk strategies for platelets
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE